Product NDC: | 52584-556 |
Proprietary Name: | Kinevac |
Non Proprietary Name: | Sincalide |
Active Ingredient(s): | 5 ug/5mL & nbsp; Sincalide |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52584-556 |
Labeler Name: | General Injectables & Vaccines, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA017697 |
Marketing Category: | NDA |
Start Marketing Date: | 20101105 |
Package NDC: | 52584-556-15 |
Package Description: | 1 VIAL in 1 BAG (52584-556-15) > 5 mL in 1 VIAL |
NDC Code | 52584-556-15 |
Proprietary Name | Kinevac |
Package Description | 1 VIAL in 1 BAG (52584-556-15) > 5 mL in 1 VIAL |
Product NDC | 52584-556 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Sincalide |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20101105 |
Marketing Category Name | NDA |
Labeler Name | General Injectables & Vaccines, Inc |
Substance Name | SINCALIDE |
Strength Number | 5 |
Strength Unit | ug/5mL |
Pharmaceutical Classes | Cholecystokinin [Chemical/Ingredient],Cholecystokinin Analog [EPC] |